Cardinal Health (NYSE:CAH)‘s stock had its “hold” rating reiterated by equities research analysts at Mizuho in a research note issued to investors on Sunday. They presently have a $53.00 price objective on the stock. Mizuho’s price target suggests a potential upside of 8.03% from the stock’s current price.

Several other research firms also recently issued reports on CAH. Zacks Investment Research raised Cardinal Health from a “strong sell” rating to a “hold” rating in a research note on Tuesday, July 3rd. Robert W. Baird reaffirmed a “hold” rating and set a $51.00 price target on shares of Cardinal Health in a research note on Friday, July 20th. Jefferies Financial Group set a $55.00 price target on Cardinal Health and gave the stock a “hold” rating in a research note on Friday, May 4th. Leerink Swann set a $65.00 price target on Cardinal Health and gave the stock a “buy” rating in a research note on Saturday, May 5th. Finally, Morgan Stanley dropped their price objective on Cardinal Health from $55.00 to $40.00 and set an “underweight” rating for the company in a research report on Tuesday, July 3rd. Four equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and three have given a buy rating to the company. Cardinal Health has a consensus rating of “Hold” and an average target price of $62.00.

NYSE:CAH opened at $49.06 on Friday. The firm has a market cap of $15.04 billion, a PE ratio of 9.81, a PEG ratio of 1.78 and a beta of 0.99. The company has a debt-to-equity ratio of 1.32, a current ratio of 1.07 and a quick ratio of 0.54. Cardinal Health has a 52-week low of $48.14 and a 52-week high of $75.75.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Monday, August 6th. The company reported $1.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.93 by $0.08. The business had revenue of $35.35 billion during the quarter, compared to the consensus estimate of $34.38 billion. Cardinal Health had a return on equity of 22.59% and a net margin of 0.19%. The business’s revenue was up 7.2% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.31 EPS. analysts expect that Cardinal Health will post 5.04 EPS for the current fiscal year.

A number of institutional investors have recently bought and sold shares of CAH. Signaturefd LLC purchased a new stake in Cardinal Health during the 1st quarter worth about $100,000. Optimum Investment Advisors purchased a new stake in Cardinal Health during the 1st quarter worth about $128,000. Sentry Investment Management LLC purchased a new stake in Cardinal Health during the 2nd quarter worth about $132,000. Mount Yale Investment Advisors LLC purchased a new stake in Cardinal Health during the 1st quarter worth about $136,000. Finally, Focused Wealth Management Inc purchased a new stake in Cardinal Health during the 1st quarter worth about $166,000. Hedge funds and other institutional investors own 89.98% of the company’s stock.

About Cardinal Health

Cardinal Health, Inc operates as an integrated healthcare services and products company worldwide. The company's Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare, and consumer products to retailers, hospitals, and other healthcare providers.

See Also: Stock Symbol

Analyst Recommendations for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.